
Aflac Incorporated (NYSE:AFL – Free Report) – Equities research analysts at DOWLING & PARTN lifted their FY2026 earnings per share estimates for shares of Aflac in a note issued to investors on Tuesday, November 10th. DOWLING & PARTN analyst J. Hurwitz now expects that the financial services provider will post earnings of $7.68 per share for the year, up from their previous estimate of $7.00. The consensus estimate for Aflac’s current full-year earnings is $7.37 per share.
Aflac (NYSE:AFL – Get Free Report) last issued its quarterly earnings data on Wednesday, November 4th. The financial services provider reported $2.43 earnings per share for the quarter, topping analysts’ consensus estimates of $1.80 by $0.63. Aflac had a return on equity of 12.82% and a net margin of 21.24%. The firm had revenue of $4.30 billion during the quarter, compared to analysts’ expectations of $4.12 billion. During the same period in the prior year, the business posted $2.49 EPS. The firm’s quarterly revenue was down 31.0% on a year-over-year basis.
A number of other research analysts also recently issued reports on AFL. Barclays reaffirmed an “underweight” rating and issued a $101.00 price objective (up from $99.00) on shares of Aflac in a research report on Wednesday, October 7th. Bank of America reduced their price objective on shares of Aflac from $137.00 to $133.00 and set a “buy” rating for the company in a research note on Monday, October 12th. Piper Sandler increased their target price on shares of Aflac from $138.00 to $143.00 and gave the company an “overweight” rating in a research report on Monday, November 9th. Wolfe Research began coverage on shares of Aflac in a research note on Wednesday, August 19th. They issued an “underperform” rating and a $103.00 target price for the company. Finally, Wells Fargo & Company lifted their price target on shares of Aflac from $116.00 to $124.00 and gave the stock an “equal weight” rating in a report on Thursday, November 12th. One research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating, eight have assigned a Hold rating and four have given a Sell rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $118.73.
Get Our Latest Stock Analysis on Aflac
Aflac Stock Performance
Shares of Aflac stock opened at $127.83 on Monday. The company has a market capitalization of $63.22 billion, a PE ratio of 16.87, a P/E/G ratio of 1.78 and a beta of 0.55. The company has a 50-day simple moving average of $118.68 and a two-hundred day simple moving average of $116.76. Aflac has a one year low of $105.76 and a one year high of $131.18. The company has a debt-to-equity ratio of 0.30, a quick ratio of 0.11 and a current ratio of 0.11.
Aflac Increases Dividend
The firm also recently declared a quarterly dividend, which will be paid on Monday, March 1st. Shareholders of record on Wednesday, February 17th will be paid a $0.64 dividend. This represents a $2.56 dividend on an annualized basis and a yield of 2.0%. This is a boost from Aflac’s previous quarterly dividend of $0.61. The ex-dividend date is Wednesday, February 17th. Aflac’s dividend payout ratio (DPR) is 35.57%.
Insider Activity
In other news, major shareholder Post Holdings Co. Ltd. Japan sold 12,900 shares of the company’s stock in a transaction dated Thursday, November 12th. The shares were sold at an average price of $126.99, for a total transaction of $1,638,171.00. Following the transaction, the insider owned 50,095,429 shares in the company, valued at $6,361,618,528.71. This represents a 0.03% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Joseph L. Moskowitz sold 600 shares of the company’s stock in a transaction dated Monday, November 9th. The shares were sold at an average price of $124.99, for a total transaction of $74,994.00. Following the transaction, the director owned 32,119 shares in the company, valued at approximately $4,014,553.81. This trade represents a 1.83% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders sold 684,362 shares of company stock valued at $79,907,885. Corporate insiders own 0.80% of the company’s stock.
Institutional Trading of Aflac
A number of institutional investors have recently bought and sold shares of the stock. Lighthouse Investment Partners LLC acquired a new position in shares of Aflac in the 3rd quarter valued at $20,707,000. WCG Wealth Advisors LLC acquired a new stake in Aflac during the 3rd quarter worth about $268,000. Keel Point LLC lifted its position in Aflac by 15.8% during the 3rd quarter. Keel Point LLC now owns 8,248 shares of the financial services provider’s stock worth $922,000 after acquiring an additional 1,127 shares during the period. Waterloo Capital L.P. grew its stake in Aflac by 77.9% during the 3rd quarter. Waterloo Capital L.P. now owns 5,489 shares of the financial services provider’s stock valued at $614,000 after purchasing an additional 2,404 shares during the last quarter. Finally, Redwood Investment Management LLC grew its stake in Aflac by 9.2% during the 3rd quarter. Redwood Investment Management LLC now owns 10,845 shares of the financial services provider’s stock valued at $1,212,000 after purchasing an additional 918 shares during the last quarter. 67.44% of the stock is currently owned by institutional investors and hedge funds.
Aflac Company Profile
Aflac Incorporated is an insurance company that provides supplemental health and life insurance to individuals and businesses. Its products are designed to help customers manage expenses that may not be covered by major medical insurance, including costs associated with accidents, cancer, critical illness and hospital stays. The company operates primarily in the United States and Japan. In the U.S., Aflac offers workplace benefits such as accident, disability, dental, vision and life insurance. In Japan, it provides products including cancer, medical and life insurance.
Featured Articles
- Five stocks we like better than Aflac
- Ondas Is Building a Defense Growth Engine, But Can It Deliver on Its Backlog?
- Orbiting Growth: Federal Contracts Boost Viasat’s Outlook
- Modine Manufacturing Scales Up to Solve the AI Heat Problem
- Nebius Revenue Is Surging, But Its Spending Is Raising Bigger Questions
Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.
